Search Results - Susan O'Brien

Refine Results
  1. 1
    Initial treatment of CLL: integrating biology and functional status

    Initial treatment of CLL: integrating biology and functional status by Nitin Jain, Susan O’Brien

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Reply to myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: Analysis of persistent and new‐onset cytopenia

    Reply to myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: Analysis of persistent and new‐onset cytopenia... by Paolo Strati, Susan O’Brien

    Published 2013
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  3. 3
    Immune defects in patients with chronic lymphocytic leukemia

    Immune defects in patients with chronic lymphocytic leukemia by Farhad Ravandi, Susan O’Brien

    Published 2005
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Update on Therapy of Chronic Lymphocytic Leukemia

    Update on Therapy of Chronic Lymphocytic Leukemia by John G. Gribben, Susan O’Brien

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Chronic Lymphocytic Leukemia: Diagnosis and Treatment

    Chronic Lymphocytic Leukemia: Diagnosis and Treatment by Paolo Strati, Nitin Jain, Susan O’Brien

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]

    Treatment of chronic myelogenous leukemia: current status and investigational options [see comments] by HM Kantarjian, Susan O’Brien, Paolo Anderlini, Moshe Talpaz

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Discontinuation of imatinib therapy after achieving a molecular response

    Discontinuation of imatinib therapy after achieving a molecular response by Jorge E. Cortés, Susan O’Brien, Hagop M. Kantarjian

    Published 2004
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  8. 8
    Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval

    Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval by Hagop M. Kantarjian, Susan O’Brien, Jorge E. Cortés

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Advances in the biology and treatment of B-cell chronic lymphocytic leukemia

    Advances in the biology and treatment of B-cell chronic lymphocytic leukemia by Susan O’Brien, Auro del Giglio, Michael J. Keating

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Acute lymphoblastic leukemia in adolescents and young adults

    Acute lymphoblastic leukemia in adolescents and young adults by Michael Rytting, Elias Jabbour, Susan O’Brien, Hagop M. Kantarjian

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Monoclonal antibodies in acute lymphoblastic leukemia

    Monoclonal antibodies in acute lymphoblastic leukemia by Elias Jabbour, Susan O’Brien, Farhad Ravandi, Hagop M. Kantarjian

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia

    New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia by Elias Jabbour, Susan O’Brien, Marina Konopleva, Hagop M. Kantarjian

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia

    Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia by Hagop M. Kantarjian, Deborah A. Thomas, Alan S. Wayne, Susan O’Brien

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Recent advances in de novo CD5<sup>+</sup> diffuse large B cell lymphoma

    Recent advances in de novo CD5<sup>+</sup> diffuse large B cell lymphoma by Preetesh Jain, Luis Fayad, Andreas Rosenwald, Ken H. Young, Susan O’Brien

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis

    Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis by Amit Bar‐Or, Susan O’Brien, Michael Sweeney, Edward Fox, Jeffrey A. Cohen

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemia

    Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemia by Michael Rytting, Lisa Triche, Deborah A. Thomas, Susan O’Brien, Hagop M. Kantarjian

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Imatinib mesylate causes hypopigmentation in the skin

    Imatinib mesylate causes hypopigmentation in the skin by Anne S. Tsao, Hagop M. Kantarjian, Jorge E. Cortés, Susan O’Brien, Moshe Talpaz

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia

    Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine... by Kensuke Kojima, Marina Konopleva, Teresa McQueen, Susan O’Brien, William Plunkett, Michael Andreeff

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Philadelphia-Positive Acute Lymphoblastic Leukemia: Current Treatment Options

    Philadelphia-Positive Acute Lymphoblastic Leukemia: Current Treatment Options by Theresa Liu-Dumlao, Hagop M. Kantarjian, Deborah A. Thomas, Susan O’Brien, Farhad Ravandi

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Current and emerging treatment options in chronic myeloid leukemia

    Current and emerging treatment options in chronic myeloid leukemia by Elias Jabbour, Jorge E. Cortés, Francis J. Giles, Susan O’Brien, Hagop M. Kantarjian

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: